This is messed up. I've been hacked! Ok fist off you cannot wipe my brain free Google (can you>?) I can still describe that video and you cannot stop me.. Ok think Crazy Rich Asians... (sorry that's the name of a movie) think Glam and poolside and two very glamorous (Asian) ladies are talking and one says something to the effect of I can do that I'll wear my so and so and the other is wearing a Tiara in her hair and the whole scene is very Princess/ Grecian looking Robin Hood is involved somehow... and the girls have dome flowing capes --It's now poolside, and one of the ladies I guess her plan was to wear this red bikini and she emerges and walks and it's mind boggling good action. It's the acting and the look. Total package. Assertive, smart, in control, red bikini. And that's' pretty much it. It actually was an incredible relief from the strains of investing. But you want to go toe to toe... Alright mr Google... take this!
Ok I may be no tech. But I am a darn good reporter. And I can search and dig better than most ok... So I have found the show! And Indeed it exists I am not crazy. This is a strange show. I cannot tel where it comes from Brazil? It seems like a regular show except the bikini part again this scene a bikini no big deal the action and the acting is superior. This is not as good a scene as the last one but a good test of this Hacking by Mr Google. This is free info... AIRED (September 05, 2017):<-- Ok and then they tried to slip some mumbo jumbo that may be a language and it maybe code... Paano kaya maniniwala sina PO1 Cruz at Pepe na may nagtatangka sa buhay ni Iris, kung nangangamoy alak siya at nakasuot pa ng swimsuit habang nagda-drive? Don't click that! But as a test Lets see if this is still America.
I am totally hooked on this show. Watching again later today... I believe it is a Filipino television show.. & it;s dang good a cross between power rangers and Robin Hood and Chips? For now though we have to get the word out to Robin Hood that Rabies is Serious Stuff--- Not to be taken lightly and even though you were expecting Covid news you shouldn't be dumping on a nice biotech like KMDA for coming out with good news about rabies! The fight against rabies continues! Join Us! Be One. STOP THE DROOL!
Kamada and Kedrion Biopharma Announce Results of First and Only U.S. Post-Marketing Pediatric Trial of a Human Rabies Immune Globulin (HRIG); The Study Met Its Primary Objective Kamada Ltd. , GlobeNewswire•August 19, 2020 The Study of KEDRAB® (Rabies Immune Globulin [Human]) Conducted in Children was the First and Only Pediatric Study for any HRIG Available in U.S. The Study Met its Primary Objective, Which Was to Confirm the Safety of KEDRAB in the Pediatric Population. Study Results Have Been Submitted to the U.S. FDA for Review and Potential Update to the KEDRAB Prescribing Information. KEDRAB was Launched in the U.S. in 2018 and it Generated In-Market Sales of $31 Million in 2019, Representing Approximately 20 Percent Share of the U.S. HRIG Market. (Ok Hold up Mr Hood... potential Update to prescribing info =$$$$$$) KEDRAB is a human rabies immunoglobulin (HRIG) indicated for passive, transient post-exposure prophylaxis (PEP) treatment of rabies infection, when given promptly after contact with a rabid or possibly rabid animal.-- Kamada Ltd. (NASDAQ & TASE: KMDA) and Kedrion Biopharma, two leading biopharmaceutical companies specialized in plasma-derived protein therapeutics, today announced results from a U.S. post-marketing pediatric trial of KEDRAB® (Rabies Immune Globulin [Human]). The study represents the first and only trial of a currently available human rabiesimmune globulin (HRIG) conducted in children in the U.S. to date. The results have been submitted to the U.S. Food and Drug Administration for review and inclusion as pediatric data in the KEDRAB full prescribing information. KEDRAB is a human rabies immunoglobulin (HRIG) indicated for passive, transient post-exposure prophylaxis (PEP) treatment of rabies infection, when given promptly after contact with a rabid or possibly rabid animal. The KEDRAB U.S. Pediatric Trial was conducted at two sites, one in Arkansas and another in Rhode Island. The study included 30 pediatric patients (ages 0-17 years old), each of whom received KEDRAB as part of PEP treatment following exposure or suspected exposure to an animal suspected or confirmed to be rabid, and safety follow-up was conducted for up to 84 days. The primary objective of the study was to confirm the safety of KEDRAB in the pediatric population. Secondary objectives included the evaluation of antibody levels and the efficacy of KEDRAB in the prevention of rabies disease when administered with a rabies vaccine according to the PEP recommended guidelines. No serious adverse events were observed during the study. No incidence of rabies disease or deaths were recorded throughout the 84-day study period. “These key study results represent the first clinical trial data in the U.S. pediatric population for any HRIG currently available in the US,” said Michal Stein, M.D., Vice President, Medical Director (Immunology) at Kamada. “According to the World Health Organization, 40 percent of people bitten by suspected rabid animals are children under 15 years of age. Despite the large proportion of pediatric cases, limited safety and efficacy data from clinical trials currently exist for this population. Meeting the primary study objective of KEDRAB in children further strengthens our ongoing confidence in the product. We continue to believe that sales of KEDRAB has the potential to continue growing in the U.S., capturing a significant share of the estimated annual $150 million U.S. HRIG market.” KEDRAB was launched in the U.S. in April 2018 and generated in-market sales of $31 million in 2019, representing approximately 20 percent of the U.S. HRIG market. (Ok... Mr Hood--so KMDA should now be first in class and grab more share of the rabies market! If 20% becomes 40% then $31 mil becomes $62 mil... not bad not bad at all that will help pay for the upcoming COVID Plasma trials... Not everything can be a Billion $ opportunity in biotech sometimes we just have to help people that have been bit! Listen one year we had two bats in the house.. If I had been bit what would I have done? we had a rabid racoon one year came right at my landscaper/helper who fended him off with a Chainsaw! and he kept coming.. I watched the whole thing half way up a tree... Stuff happens in the woods Bobcats... yup.. and in Australia this is an issue when dogs jump of boats ans they often do.. Ah The French! Always with the dog...) Lets Not Punish some Good people in Israel for coming out with news that is not Covid related... patience...
>>>>BREAKING NEWS!>>>>>>>> Penn National falls after Barstool's Portnoy says he may have COVID 12:21 PENN Shares of Penn National Gaming fell after Barstool Sports founder Dave Portnoy posted on Twitter that he may have COVID-19. Portnoy said in a video that he hasn't gotten out of bed in 40 hours and is very sick. Penn National acquired a 36% interest in Barstool Sports for about $163M in cash and convertible preferred stock in January. After rallying earlier, shares of Penn National are down 1.5% to $54.54 in midday trading... This is very interesting and has to be watched. The market may not like it if Mr Portnoy has a bad Covid outcome this may trigger some stock reality check- that Herman Cain did not
What is Light In The Box. This vid is in German but the site he's looking at is Light In The Box in China. This is some weird mobile ordering site. LITB.
LightInTheBox Stock Volatile After Company Reports Impressive Revenue Growth Investors might not like the uncertainty baked into third-quarter guidance, especially considering the profits they can book now. Aug 19, 2020 at 12:13PM What happened Chinese e-commerce company LightInTheBox Holding (NYSE:LITB) reported results for the second quarter of 2020 demonstrating impressive revenue growth and profitability. And investors apparently loved the report before the market opened. The stock opened 26% higher than where it closed the day before. However, LightInTheBox stock has been free-falling since, down 8% as of 11 a.m. EDT. So what LightInTheBox sells directly and ships directly from its e-commerce sites, and operates multiple countries. Due to customer retention, new customer acquisition, and increased spending from existing customers, Q2 revenue surged 96% year over year to $114 million. While e-commerce got a boost from the COVID-19 pandemic, not all e-commerce companies saw this level of growth. Furthermore, LightInTheBox turned in a profitable quarter. Q2 net income was $8.5 million, compared to a net loss of $7.3 million last year. The company attributed the marked improvement to a strategy shift in recent quarters. It's now focused on selling higher-margin products, which boosts the bottom line. Now what It was a very strong quarter for this small-cap company, making LightInTheBox stock's volatility puzzling. In the earnings call, management didn't offer a warning or downside guidance. However, there was uncertainty in the guidance for the third quarter. It expects net revenue of $95 million to $110 million, representing year-over-year growth between 59% and 83%. That's a very wide range and it possibly injected enough uncertainty to motivate shareholders to take some profits off the table -- the stock traded under $1 per share earlier this year.
I will tell you one funny thing about that conference call it's the first time I can remember there being no analysts there to ask questions.. It just stopped.